Abstract
Cerebrovascular disease continues to be a major source of morbidity and mortality in our aging population. Cerebrovascular disease continues to present challenges in the diagnostic and therapeutic arena. Prevention and treatment of stroke represent an unconquered frontier in clinical neuroscience. The ability to identify and treat cerebrovascular abnormalities before permanent ischemic deficit occurs is rapidly increasing. Endovascular therapy of vascular malformations and vasospasm are today a necessary comparison with microsurgery; cerebral blood flow measurements tool give clinicians the opportunity to identify patients at risk for ischemic damage and to suggest new therapeutic paths; minimally invasive diagnostic tools are gradually reducing the indication for cerebral angiography.
Such major advances in technology, that are actually changing our therapeutic approach to cerebrovascular disease, and to cerebral aneurysms treatment, will soon result in safer more effective treatments, minimizing the onset of permanent neurologic deficits. Anyway, it is a fact that the majority of cerebral aneurysms are still treated by microsurgery, either because of the wider diffusion of specialized centers offering this technique, or because of the longer follow up on the obtained results achieved by neurosurgeons. The object of the present study is to show how the surgical treatment of cerebral aneurysms is organized, and which are the main problems that neurosurgeons are facing in the effort to conjugate microsurgical treatment with the new ancillary technologies for the study of cerebrovascular malformations.
Get full access to this article
View all access options for this article.
